Novartis Ag Adr Stock Price on April 16, 2024
NVS Stock | USD 97.50 0.37 0.38% |
Below is the normalized historical share price chart for Novartis AG ADR extending back to May 11, 2000. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Novartis stands at 97.50, as last reported on the 2nd of May, with the highest price reaching 97.50 and the lowest price hitting 97.50 during the day.
If you're considering investing in Novartis Stock, it is important to understand the factors that can impact its price. Novartis AG ADR has Sharpe Ratio of -0.0338, which conveys that the firm had a -0.0338% return per unit of risk over the last 3 months. Novartis exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Novartis' Mean Deviation of 0.8379, standard deviation of 1.13, and Risk Adjusted Performance of (0.04) to check out the risk estimate we provide.
At this time, Novartis' Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 103.1 B in 2024, whereas Common Stock Total Equity is likely to drop slightly above 776.8 M in 2024. . At this time, Novartis' Price To Operating Cash Flows Ratio is comparatively stable compared to the past year. Price To Free Cash Flows Ratio is likely to gain to 19.28 in 2024, whereas Price Earnings Ratio is likely to drop 13.62 in 2024. Novartis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of November 1991 | 200 Day MA 99.7551 | 50 Day MA 97.8136 | Beta 0.475 |
Novartis |
Sharpe Ratio = -0.0338
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | NVS |
Estimated Market Risk
1.0 actual daily | 8 92% of assets are more volatile |
Expected Return
-0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Novartis is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Novartis by adding Novartis to a well-diversified portfolio.
Price Book 4.0962 | Enterprise Value Ebitda 11.2733 | Price Sales 4.145 | Shares Float 1.9 B | Dividend Share 3.919 |
Related Headline
Bristol Myers Headline on 16th of April 2024
GE Aerospace Takes Center Stage in T. Rowe Price Equity Inco... by gurufocus.com
Insight into the Funds Latest Investment Moves and Stock Market Strategies T. Rowe Price Equity Income Fund, known for its conservative and value-oriented inv
Novartis Valuation on April 16, 2024
It is possible to determine the worth of Novartis on a given historical date. On April 16, 2024 Novartis was worth 92.85 at the beginning of the trading date compared to the closed value of 93.2. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Novartis stock. Still, in general, we apply an absolute valuation method to find Novartis' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Novartis where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Novartis' related companies.
Open | High | Low | Close | Volume | |
94.20 | 94.97 | 94.11 | 94.41 | 1,501,022 | |
04/16/2024 | 92.85 | 93.37 | 92.64 | 93.20 | 1,914,845 |
93.63 | 93.78 | 92.87 | 93.08 | 1,168,714 |
Backtest Novartis | | | Novartis History | | | Novartis Valuation | Previous | Next |
Novartis Trading Date Momentum on April 16, 2024
On April 17 2024 Novartis AG ADR was traded for 93.08 at the closing time. Highest Novartis's price during the trading hours was 93.78 and the lowest price during the day was 92.87 . The net volume was 1.2 M. The overall trading history on the 17th of April 2024 contributed to the next trading period price depreciation. The trading delta at closing time to the next next day price was 0.13% . The trading delta at closing time to current price is 4.89% . |
Novartis AG ADR Fundamentals Correlations and Trends
By evaluating Novartis' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Novartis' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Novartis financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Novartis Stock history
Novartis investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Novartis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Novartis AG ADR will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Novartis stock prices may prove useful in developing a viable investing in Novartis
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 2.1 B | 1.9 B | |
Net Income Applicable To Common Shares | 8 B | 9.8 B |
Novartis Stock Technical Analysis
Novartis technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Novartis Period Price Range
Low | April 16, 2024
| High |
92.85 | 93.20 |
Novartis May 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Novartis stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Novartis shares will generate the highest return on investment. By undertsting and applying Novartis stock market strength indicators, traders can identify Novartis AG ADR entry and exit signals to maximize returns
Accumulation Distribution | 14970.94 | |||
Daily Balance Of Power | 0.4795 | |||
Rate Of Daily Change | 1.0 | |||
Day Median Price | 93.01 | |||
Day Typical Price | 93.07 | |||
Price Action Indicator | 0.37 | |||
Period Momentum Indicator | 4.3 |
Novartis Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Novartis' price direction in advance. Along with the technical and fundamental analysis of Novartis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Novartis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.04) | |||
Jensen Alpha | (0.12) | |||
Total Risk Alpha | (0.18) | |||
Treynor Ratio | (0.17) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novartis AG ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Novartis Stock analysis
When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |
Is Novartis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novartis. If investors know Novartis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novartis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.215 | Dividend Share 3.919 | Earnings Share 4.4 | Revenue Per Share 23.168 | Quarterly Revenue Growth 0.097 |
The market value of Novartis AG ADR is measured differently than its book value, which is the value of Novartis that is recorded on the company's balance sheet. Investors also form their own opinion of Novartis' value that differs from its market value or its book value, called intrinsic value, which is Novartis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novartis' market value can be influenced by many factors that don't directly affect Novartis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novartis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Novartis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novartis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.